CTRI/2023/05/053068尚未招募Unknown
Pilot study to evaluate the role Lu-177 Trastuzumab in patients with HER2 positive metastatic carcinoma breast
Ashok Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with HER2 positive carcinoma breast metastatic disease
- •-progressed on previous therapy with anti HER2 targeted agents or cardiotoxicity to trastuzumab
- •-tumor positive on low dose Lu-177 Trastuzumab scan
- •-Patients will be asked to undergo baseline evaluation and should have adequate organ function
排除标准
- •-patient allergic to trastuzumab
- •-pregnant and lactating females
研究者
相似试验
尚未招募
1 期
nderstanding the role of TLX591 in patients with metastatic Prostate cancer who failed 2 cycles of Lutetium PSMA therapyMetastatic Prostate CancerACTRN12623000216617Mercy Radiology10
尚未招募
2 期
Effectiveness of Lu177-PSMA in treatment of refractory thyroid papillary cancer.IRCT20230803059015N1Shiraz University of Medical Sciences10
尚未招募
2 期
A study to evaluate the effectiveness of 177-Lu-DOTA Rituximab drug in adult patients diagnosed with the recurrence of low-grade B-cell lymphomas (a type of blood cancer).CTRI/2021/02/031578Tata Research Administrative Council TRAC
尚未招募
2 期
Effect of Lu177-dotatate in meningiomaMeningioma.Malignant neoplasm of meninges, unspecifiedC70.9IRCT20190623043986N1Shiraz University of Medical Sciences10
进行中（未招募）
2 期
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate CancerProstate CancerNCT00859781Weill Medical College of Cornell University55